TABLE 3.
Distribution of combined GM 1,17 5,13 and KM 3 phenotypes in relation to persistence and clearance of HCV infection
| Phenotypes | No. (%) of subjectsa with indicated HCV infection outcome
|
OR | 95% confidence interval | P | |
|---|---|---|---|---|---|
| Persistent | Cleared | ||||
| GM 1,17 5,13 (+)/KM 3 (+) | 28 (14.4) | 11 (11.5) | 0.90 | 0.40-2.03 | 0.80 |
| GM 1,17 5,13 (+)/KM 3 (−) | 16 (8.3) | 18 (18.8) | 2.75 | 1.21-6.23 | 0.01 |
| GM 1,17 5,13 (−)/KM 3 (+) | 75 (38.7) | 35 (36.5) | 1.02 | 0.57-1.83 | 0.94 |
| GM 1,17 5,13 (−)/KM 3 (−) | 75 (38.7) | 32 (33.3) | 1.00 | ||
a
Persistence, n = 194; clearance, n = 96; missing GM and/or KM typing, n = 8.